LAGUNA HILLS, CA, FEBRUARY 19, 2013 – NanoSmart® Pharmaceuticals, a private biopharmaceutical company developing a novel drug delivery platform, was honored with the On the Rise award at the 17th Annual Drug Delivery Partnerships Conference held in San Diego, February 6-8. The award is given to honor those companies and innovators from the past year that have demonstrated exemplary leadership or developed a technology that will likely drive the drug delivery industry forward in the years to come.
"We are very proud to have NanoSmart as Drug Delivery Partnerships' 2013 On the Rise award recipient," said Heather King, Event Director. "It shows that the drug delivery industry believes NanoSmart is an exciting, up-and-coming company. We look forward to its continued success."
Dr. James Smith, President of NanoSmart, was also among the senior executives who presented during the Drug Delivery Technology Innovations track. Dr. Smith explained how NanoSmart's approach to drug delivery complements the industry's current trends toward broad collaboration, targeted delivery, and increased focus on drug products for rare and pediatric diseases.
"It's an honor to be recognized as a rising player in the pharmaceutical industry," explained Dr. Smith. "This conference presented us with an exceptional opportunity to engage directly with many different industry resources and other pharmaceutical executives and to lay the groundwork for future collaborations."
About NanoSmart Pharmaceuticals
NanoSmart Pharmaceuticals, Inc. (www.nanosmartpharma.com) is developing novel drug delivery products to treat cancer and other serious life-threatening diseases. NanoSmart's patented platform drug delivery system utilizes human-derived antinuclear antibodies that target areas of necrosis present in many different types of solid tumors and other diseases. NanoSmart has completed development of its preliminary targeted nanoparticle formulations and is currently engaged in preclinical testing of its lead candidate drug products.
About Drug Delivery Partnerships
The Drug Delivery Partnerships Conference is the longest running and most respected drug delivery business conference in the biopharmaceutical industry. Bringing together representatives from over 280 companies and 36 countries, the event offers extensive networking and educational opportunities in the areas of partnering strategies, product life cycle management, and development strategies. The 18th Annual Event will be held January 27-29, 2014, in Boca Raton, FL. For more information, please visitwww.drugdeliverypartnerships.com.
This press release may contain forward-looking statements. There can be no assurance that development efforts will succeed; or that the novel biopharmaceuticals will receive regulatory clearance, or achieve commercial success.
Media Relations:
Anthony Galasso
LifeSciencePR
973.263.5296
[email protected]
Investor Relations:
Dan Thiel
NanoSmart Pharmaceuticals, Inc.
949.305.2020
[email protected]